Jan van Bodegom

Jan van Bodegom

Company: Coretag

Job title: Chief Executive Officer


Targeted Alpha Therapy: The Future of Effective Cancer Therapy Using Alpha Emitting Isotopes 1:00 pm

Single alpha-emitting isotopes: how to avoid delayed damage? Ideal half-life: can you combine effectiveness with minimal side effects? Reliable supply: how to secure a strong and reliable supply chainRead more

day: Track B

Necrosis Targeting Radiopharmaceuticals 5:00 pm

Necrosis Targeting Diagnostics to help clinical decision making Necrosis Targeting Alpha and Beta therapy Necrosis Targeting Radiotherapy the path from concept to clinicRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.